NCT02320409View on ClinicalTrials.gov

A Food Effect Phase I Study of the Sulfatinib in Healthy Subjects (HMPL-012)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

Sulfatinib

250mg Sulfatinib ,single dose,oral

Trial Locations (1)

200031

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Hutchison Medipharma Limited

INDUSTRY

NCT02320409 - A Food Effect Phase I Study of the Sulfatinib in Healthy Subjects (HMPL-012) | Biotech Hunter | Biotech Hunter